arabinofuranosylcytosine triphosphate has been researched along with Kahler Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexanian, R; Barlogie, B; Dreicer, R; Kantarjian, H; Plunkett, W | 1 |
1 other study(ies) available for arabinofuranosylcytosine triphosphate and Kahler Disease
| Article | Year |
|---|---|
High-dose cytosine arabinoside in multiple myeloma.
Topics: Aged; Arabinofuranosylcytosine Triphosphate; Blood Cell Count; Bone Marrow; Bone Marrow Diseases; Cell Count; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Interphase; Male; Middle Aged; Multiple Myeloma | 1984 |